Regulatory PathRegulatory requirements compared

Active substance

Hyaluronic acid

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
Auralya30 mg/mlGel for injection · Subcutaneous use2 Pre-filled syringeSAR 359.35Generic · PrescriptionIRA Instituto Ricerche Applicate SpAValid
Auralya25 mg/mlGel for injection · Subcutaneous use2 Pre-filled syringeSAR 329.10Generic · PrescriptionIRA Instituto Ricerche Applicate SpAValid
Auralya20 mg/mlGel for injection · Subcutaneous use1 Pre-filled syringeSAR 298.85Generic · PrescriptionIRA Instituto Ricerche Applicate SpAValid
CRESPINE GEL FOR INJECTION1 mgGel · Intraarticular use1 Pre-filled syringeSAR 463.15Generic · PrescriptionBiopolymer GmbH & Co. KgValid
DERMALAX PLUS INJECTION20 mg/mlInjection · Intradermal use1 BottleSAR 224.55Generic · PrescriptionAcross Co., LtdValid
Dermafill Volume Ultra20 mg/mlGel · Intradermal use1 Pre-filled syringeSAR 241.70Generic · PrescriptionSBS MED INFINITY COSMETICS SASValid
Evanthia25 mg/mlGel for injection · Subcutaneous use2 Pre-filled syringeSAR 447.70Generic · PrescriptionIRA Instituto Ricerche Applicate SpAValid
Evanthia20 mg/mlGel for injection · Subcutaneous use2 Pre-filled syringeSAR 375.10Generic · PrescriptionIRA Instituto Ricerche Applicate SpAValid
Evanthia15 mg/mlGel for injection · Subcutaneous use2 Pre-filled syringeSAR 247.10Generic · PrescriptionIRA Instituto Ricerche Applicate SpAValid
HY-LIGHT0.2 %Eye drops · Ocular use1 BottleSAR 14.10Generic · OTCFarmigea S.p.AValid
HYE MONO EYE DROPS0.4 %Eye drops, solution · Ocular use20 Single Dose ContainerSAR 25.60Generic · OTCFarmigea S.p.AValid
HYE MULTI EYE DROPS0.4 %Eye drops, solution · Ocular use1 BottleSAR 14.10Generic · OTCFarmigea S.p.AValid
HYFRESH 2 MG- ML OPHTHALMIC SOLUTION2 %Eye drops · Ophthalmic use1 Dropper ContainerSAR 34.15Generic · OTCJamjoom Pharmaceuticals Factory CompanyValid
Hyaprof Balance22 mg/mlGel · Intradermal use2 Pre-filled syringeSAR 467.22Generic · PrescriptionBioscience GmbHValid
Hyaprof Soft20 mg/mlGel · Intradermal use2 Pre-filled syringeSAR 424.75Generic · PrescriptionBioscience GmbHValid
Jalor23 mg/mlGel · Subcutaneous use1 Injection SyringeSAR 342.35Generic · PrescriptionCROMA PHARMA GmbhValid
NEAUVIA Organic Intense28 mg/mlSolution for injection in pre-filled syringe · Intradermal use1 Pre-filled syringeSAR 324.35Generic · PrescriptionMATEX LAB SpaValid
REVANESSE25 mg/mlInjection · Cutaneous use1 Injection SyringeSAR 585.35Generic · PrescriptionProllenium Medical Technologies IncValid
REVANESSE CONTOUR25 mg/mlInjection · Cutaneous use2 Injection SyringeSAR 680.65Generic · PrescriptionProllenium Medical Technologies IncValid
REVANESSE KISS25 mg/mlInjection · Cutaneous use2 Injection SyringeSAR 653.40Generic · PrescriptionProllenium Medical Technologies IncValid
REVANESSE PURE14 mg/mlInjection · Cutaneous use2 Injection SyringeSAR 530.60Generic · PrescriptionProllenium Medical Technologies IncValid
REVANESSE ULTRA25 mg/mlInjection · Cutaneous use2 Injection SyringeSAR 653.40Generic · PrescriptionProllenium Medical Technologies IncValid
Renee Lift26 mg/mlSolution for injection/infusion in pre-filled syringe · Intradermal use1 Pre-filled syringeSAR 184.13Generic · PrescriptionQventis GmbHValid
Renee Smile22 mg/mlSolution for injection in pre-filled syringe · Intradermal use1 Pre-filled syringeSAR 194.65Generic · PrescriptionQventis GmbHValid
Renee Touch24 mg/mlSolution for injection in pre-filled syringe · Intradermal use1 Pre-filled syringeSAR 184.13Generic · PrescriptionQventis GmbHValid

17 more — full table

Indications — CHI Daman Drug Formulary

OSTEOARTHRITIS

Combinations containing Hyaluronic acid

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.